n, Per cent or mean (SD) [minimum–maximum] | |
---|---|
Gender (males) | 153 (62%) |
Age (years) | 51 (12) [24–79] |
Diagnosis duration (years) | 16.8 (11.8) [5–44] |
BASDAI | 4.4 (2.3) [0–10] |
BASFI | 4.2 (2.5) [0–10] |
Current use of TNF-α inhibitors (n, %) | 123 (50%) |
Higher professional education or university (n, %) | 81 (33%) |
SF-36 PCS | 38.7 (10.1) [5.2–61.9] |
SF-36 MCS | 49.2 (12.8) [10.9–70.5] |
SWLS | 22.2 (7.2) [5–35] |
SRPQ roles that are optional | |
Has a partner, intimate relationship (n, %) | 187 (79%) |
Has (step/grand) children | 184 (75%) |
Has other family | 239 (98%) |
Employment (n, %) | 140 (57%) |
Work disabled (n, %) | 59 (24%) |
Following some form of education (n, %) | 40 (16%) |
BASDAI, Bath Ankylosing Spondylitis Disease Index; BASFI, Bath Ankylosing Spondylitis Functioning Index; MCS, Mental Component Score; PCS, Physical Component Score; SF-36, 36-item Short Form Health Survey; SRPQ, Social Role Participation Questionnaire; SWLS, Satisfaction With Life Scale; TNF, tumour necrosis factor.